 | 08/11/2008 | New Test Measures Hepcidin, Can Help Diagnose Anaemias and Iron Disorders - (DGNews) |
| 08/06/2008 | Single Lot of Epoetin Alfa Recalled Due to Damaged Vials - (DGNews) |
| 01/25/2008 | Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection (JAMA) |
| 12/13/2007 | Sequential Deferiprone-Deferoxamine Tops Deferiprone Alone in Treatment of Thalassemia Major: Presented at ASH - (DGDispatch) |
| 12/13/2007 | Adding Deferiprone to Deferoxamine Decreases Beta Thalassemia Complications: Presented at ASH - (DGDispatch) |
| 12/10/2007 | Deferasirox Retains Long-Term Efficacy in Iron Overload: Presented at ASH - (DGDispatch) |
| 10/29/2007 | Splenectomy Reduces Packed Red Cell Transfusion Requirement in Children with Sickle Cell Anaemia: Presented at AAP - (DGDispatch) |
| 09/05/2007 | NIH Scientists Discover Novel Cause Of Iron Overload In Thalassemia Disorders - (DGNews) |
| 09/21/2006 | Exjade (Deferasirox), a Breakthrough Once-Daily Oral Iron Chelator, Now Available in the UK - (DGNews) |
| 06/19/2006 | Deferiprone and Deferasirox Equally Effective in Patients With Thalassemia Major: Presented at EHA - (DGDispatch) |
| 04/21/2006 | New Drug Poised to Radically Change Treatment of Severe Anemias - (DGNews) |
| 02/22/2006 | Long-Term Study Confirms the Feasibility of Cure in Patients With Thalassemia Major by Bone Marrow Transplantation: Presented at ASBMT - (DGDispatch) |
| 01/13/2006 | New Study Confirms Prior Research Showing Efficacy of Using Umbilical Cord Blood to Treat Thalassemia Patients - (DGNews) |
| 01/09/2006 | Data Show Ferriprox Is More Efficacious than Deferoxamine in Removing Iron from The Heart and in Preventing Early Death in Patients with Thalassemia - (DGNews) |
| 11/03/2005 | Exjade, a Breakthrough Once-Daily Oral Iron Chelator, Receives First Approval Worldwide in the U.S. - (DGNews) |
| 09/30/2005 | Common Form of Thalassaemia Can Be Managed without Blood Transfusion - (DGNews) |
| 06/06/2005 | Once-Daily Oral ICL670 (Deferasirox) Shows Benefits for Patients With Transfusion-Dependent Beta-Thalassaemia: Presented at EHA - (DGDispatch) |
| 12/08/2004 | Oral Iron Chelator Effective in Heavily Transfused Thalassemics: Presented at ASH - (DGDispatch) |
| 06/22/2004 | Cardiac Monitoring Essential for Preventing Heart Disease in Patients with Thalassemia - (DGNews) |
| 05/12/2004 | European Agency Extends Marketing Authorization of Ferriprox (Deferiprone), for Thalassemia Inadequately Treated by Deferoxamine - (DGDispatch) |
| 12/15/2003 | Investigational Oral Iron Chelator Shown to be as Effective as Standard Intravenous Therapy for Life-Threatening Transfusional Iron Overload in Beta Thalassemia: Presented at ASH - (DGNews) |
| 08/12/2003 | Hydroxyurea May Eliminate Transfusions In Patients With Beta-Thalassemia Major - (DGNews) |
| 05/07/2003 | Deferiprone Provides Greater Cardiac Protection In Thalassemia - (DGNews) |
| 03/14/2000 | Ferriprox (Deferiprone), For Thalassemia, Launched In Europe - (DGNews) |
| 02/23/2000 | Deferiprone, For Thalassemia, Safer Than Previously Thought - (DGNews) |
| 08/26/1999 | Ferriprox Approved In Europe For Treatment Of Iron Overload In Thalassemia Patients - (DGNews) |